Comment
doi: 10.1126/sciimmunol.aav1872.
Developing combination immunotherapies against cancer that make sense
Affiliations
- PMID: 30389799
- DOI: 10.1126/sciimmunol.aav1872
Item in Clipboard
Comment
Developing combination immunotherapies against cancer that make sense
Sci Immunol.
.
Abstract
Mechanistic preclinical studies provide a compelling case that combination immunotherapies that target the receptors PD-1 and GITR may demonstrate synergy in human cancer.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Comment on
-
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8+ T cell dysfunction and maintain memory phenotype.Sci Immunol. 2018 Nov 2;3(29):eaat7061. doi: 10.1126/sciimmunol.aat7061. Sci Immunol. 2018. PMID: 30389797
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
